Edoxaban (tosylate Monohydrate)
- CAS No.
- 1229194-11-9
- Chemical Name:
- Edoxaban (tosylate Monohydrate)
- Synonyms
- Edoxaban tosilate;edoxaban tosylate hydrate;Edoxaban Tosilate Monohydrate;Lixiana;Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate;CS-1597;Yidu Saban Mesylate;Edoxaban Tosylate Hydrate 1;Etuxaban p-toluenesulfonate;Edoxaban (TsOH salt hydrate)
- CBNumber:
- CB82645582
- Molecular Formula:
- C31H38ClN7O7S2
- Molecular Weight:
- 720.26
- MOL File:
- 1229194-11-9.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/3 13:03:20
Melting point | >252°C (dec.) |
---|---|
storage temp. | Hygroscopic, Refrigerator, under inert atmosphere |
solubility | Chloroform (Very Slightly), DMSO (Slightly), Methanol (Slightly, Sonicated) |
form | Solid |
color | White to Off-White |
Stability | Hygroscopic |
InChIKey | ZLFZITWZOYXXAW-BUZWFPPCNA-N |
SMILES | S(C1C=CC(C)=CC=1)(O)(=O)=O.N([C@@H]1C[C@@H](C(=O)N(C)C)CC[C@@H]1NC(=O)C(=O)NC1N=CC(Cl)=CC=1)C(C1SC2CN(C)CCC=2N=1)=O |&1:12,14,22,r| |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |
Edoxaban (tosylate Monohydrate) Chemical Properties,Uses,Production
Uses
Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor.
Definition
ChEBI: A hydrate that is the monohydrate of the tosylate salt of edoxaban. Used for the treatment of deep vein thrombosis and pulmonary embolism.
Clinical Use
Daichi Sankyo’s edoxaban tosilate is an orally administered coagulation factor Xa inhibitor that was approved and launched in Japan for the preventive treatment of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty, total hip arthroplasty, or hip fracture surgery. Edoxaban has been shown to have a rapid onset of anticoagulant effect due to short Tmax (1–2 h) after dosing and sustained for up to 24 h post-dose. Marketed under the brand name Lixiana, it is currently in phase III studies in the US for the prevention of stroke and systemic embolic events in patients with atrial fibrillation (AF) and venous thromboembolism (VTE).
Edoxaban (tosylate Monohydrate) Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Mehta API Pvt. Ltd. | +91-9920552082 +91-9920552082 | Maharashtra, India | 33 | 58 | Inquiry |
CVR Life sciences Pvt Ltd | +91-7386789224 +91-9912960099 | Hyderabad, India | 22 | 58 | Inquiry |
Metrochem API Private Limited | +91-4069069999 +91-4069069999 | Telangana, India | 78 | 58 | Inquiry |
Honour Lab Limited | +919845977466 | Telangana, India | 164 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
CADILA HEALTHCARE LTD | +91 2718 225001 | New Delhi, India | 110 | 58 | Inquiry |
HONOUR LAB LTD | +91-40-23710405 | New Delhi, India | 39 | 58 | Inquiry |
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Supplier | Advantage |
---|---|
Mehta API Pvt. Ltd. | 58 |
CVR Life sciences Pvt Ltd | 58 |
Metrochem API Private Limited | 58 |
Honour Lab Limited | 58 |
Pharma Affiliates | 58 |
CADILA HEALTHCARE LTD | 58 |
HONOUR LAB LTD | 58 |
A.J Chemicals | 58 |
CLEARSYNTH LABS LTD. | 58 |
SynZeal Research Pvt Ltd | 58 |
1229194-11-9(Edoxaban (tosylate Monohydrate))Related Search:
1of4
chevron_right